Culture is Care: Training Workshop for Care Workers (VerbaCurant) (VerbaCurant)

"Culture is Care: Training Workshop for Care Workers" Study

The study aims to measure the empathic capacity of healthcare professionals belonging to the Alessandria Hospital, by applying validated measuring instruments, before and after a specific training intervention. The secondary objective is to assess how the training initiative impacts on subjects with a different attitude towards cultural participation.

Study Overview

Detailed Description

The aim of this project is to identify how a medical humanities intervention can act on the empathic capacity of carers through culture. One of the aims is to introduce an additional element to overcome the problems about language, prejudices, legitimisation by stakeholders who do not yet recognise the value and importance of projects promoting the relationship between culture, wellbeing and health. "Verba Curant" is aimed at generating cultural value, with the hope that it can unite the different professional fields involved and become the heritage of the community.

The project of the Alessandria Hospital Centre in collaboration with the Holden School intends to launch a series of actions aimed at promoting the beneficial impact of culture, in particular storytelling, on the caregivers and patients of the Alessandria Hospital in order to measure how much cultural enjoyment can impact on health literacy. It is planned to define a methodological tool useful for making care workers aware of the importance of culture and dialogue with patients, as well as being able to measure their degree of literacy. The tool will be the object of a widespread training action on care workers, which will also involve all the stakeholders involved in the transmission of health information to patients.

Study Type

Interventional

Enrollment (Actual)

175

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Piedmont
      • Alessandria, Piedmont, Italy, 15121
        • Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Health professionals related to the Alessandria Hospital

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Training workshop with hands-on laboratory
Participants will undergo a training course for a total of 12 hours: 4 FAD + 8 in the laboratory. They will receive theoretical narrative medicine education with 4 hours of distance education and a practice course of storytelling and creative writing whit 8 hours of distance education in small groups, enabling discussion and interaction among participants.
Participants in training courses on creative writing and storytelling.
Placebo Comparator: Brief training course
Participants will undergo a training course for a total of 4 FAD hours. They will receive theoretical narrative medicine education with 4 hours of distance education.
Participants in training courses on only theoretical narrative medicine.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Empatic capacity
Time Frame: Before the intervention (Baseline/T0) and immediately after the intervention (Final/T1)
Assessment of the empathic capacity of health workers through the Jefferson of Empathy scale in two groups (treated and controls).
Before the intervention (Baseline/T0) and immediately after the intervention (Final/T1)
Wellbeing
Time Frame: Before the intervention (Baseline/T0) and immediately after the intervention (Final/T1)
Assessment of the wellbeing level of health workers through the PGWBI questionnaire in two groups (treated and controls).
Before the intervention (Baseline/T0) and immediately after the intervention (Final/T1)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marinella Bertolotti, Biologist, Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 18, 2021

Primary Completion (Actual)

September 6, 2022

Study Completion (Actual)

December 6, 2022

Study Registration Dates

First Submitted

May 2, 2024

First Submitted That Met QC Criteria

May 10, 2024

First Posted (Actual)

May 13, 2024

Study Record Updates

Last Update Posted (Actual)

May 13, 2024

Last Update Submitted That Met QC Criteria

May 10, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • ASO.IRFI.21.02

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Empathy

3
Subscribe